BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vitte J, Michel M, Mezouar S, Diallo AB, Boumaza A, Mege JL, Desnues B. Immune Modulation as a Therapeutic Option During the SARS-CoV-2 Outbreak: The Case for Antimalarial Aminoquinolines. Front Immunol 2020;11:2159. [PMID: 32983179 DOI: 10.3389/fimmu.2020.02159] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Nunn AVW, Guy GW, Brysch W, Botchway SW, Frasch W, Calabrese EJ, Bell JD. SARS-CoV-2 and mitochondrial health: implications of lifestyle and ageing. Immun Ageing 2020;17:33. [PMID: 33292333 DOI: 10.1186/s12979-020-00204-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
2 Devaux CA, Camoin-Jau L, Mege JL, Raoult D. Can hydroxychloroquine be protective against COVID-19-associated thrombotic events ? J Microbiol Immunol Infect 2021;54:37-45. [PMID: 33500211 DOI: 10.1016/j.jmii.2020.12.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Besaratinia A, Caliri AW, Tommasi S. Hydroxychloroquine induces oxidative DNA damage and mutation in mammalian cells. DNA Repair (Amst) 2021;106:103180. [PMID: 34298488 DOI: 10.1016/j.dnarep.2021.103180] [Reference Citation Analysis]
4 Azerang P, Yazdani M, Rayatsanati K, Tahghighi A. Newly Identified COVID-19 Drug Candidates Based on Computational Strategies. J Comput Biophys Chem 2022;21:123-37. [DOI: 10.1142/s2737416521410039] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]